Cholesterol-lowering meds have potential to downgrade COVID-19′s threat to that of the common cold
Could a simple drug that has been on the market for decades be used to treat COVID-19? A research team led by Hebrew University of Jerusalem (HU)’s Professor Yaakov Nahmias says that early research looks promising; their findings appear in this week’s Cell Press Sneak Peak.